VBI VACCINES INC (TSE:VBV) Files An 8-K Shareholder Director Nominations
Item 5.08 Shareholder Director Nominations.
On April 20, 2017, the Board of Directors of VBI Vaccines Inc.
(the Company) scheduled its 2017 Annual General and
Special Meeting of Shareholders (the 2017 Annual Meeting)
for June 22, 2017, which date is more than 30 days from the
anniversary date of the Companys 2016 Annual General and Special
Meeting of Shareholders.
The Company has set a deadline of April 26, 2017, for the receipt
of shareholder proposals submitted to Rule 14a-8 under the
Securities Exchange Act of 1934, as amended (the Exchange
Act), for inclusion in the Companys proxy materials for the
2017 Annual Meeting, which date the Company has determined to be
a reasonable time before it expects to begin to mail its proxy
materials. In order to be considered timely, any such proposal
must be received by the Company at its principal executive
offices at 222 Third Street, Suite 2241, Cambridge, MA 02142,
Attn: Secretary, no later than 5:00 p.m. Eastern Standard Time on
April 26, 2017. Any such proposal must also meet the requirements
set forth in the Companys Articles (the Articles) and the
rules and regulations of the U.S. Securities and Exchange
Commission (the SEC) in order to be eligible for inclusion
in the proxy materials for the 2017 Annual Meeting.
A copy of the Articles was attached as Exhibit 3.1 to our
registration statement on Form F-4 (File No. 333-208761), filed
with the SEC on December 23, 2015.
About VBI VACCINES INC (TSE:VBV)
VBI Vaccines Inc. is a development-stage biotechnology company. The Company’s principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company’s subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda). VBI VACCINES INC (TSE:VBV) Recent Trading Information
VBI VACCINES INC (TSE:VBV) closed its last trading session down -0.09 at 6.44 with 1,344 shares trading hands.
